Gram-negative bacteria pose a serious threat to global health because they can resist multiple antibiotics, making infections difficult to treat, according to the National Institutes of Health.
NIH awards $3.96 million to develop combination therapies for superbugs
- Post author:
- Post published:November 15, 2024
- Post category:uncategorized